These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

919 related articles for article (PubMed ID: 21150933)

  • 21. Reduction of microalbuminuria by using losartan in normotensive patients with type 2 diabetes mellitus: A randomized controlled trial.
    Agha A; Amer W; Anwar E; Bashir K
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):429-35. PubMed ID: 19414946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulse pressure or dipping pattern: which one is a better cardiovascular risk marker in resistant hypertension?
    Muxfeldt ES; Salles GF
    J Hypertens; 2008 May; 26(5):878-84. PubMed ID: 18398329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Additive antioxidative effects of azelnidipine on angiotensin receptor blocker olmesartan treatment for type 2 diabetic patients with albuminuria.
    Abe M; Maruyama N; Okada K; Matsumoto S; Matsumoto K; Soma M
    Hypertens Res; 2011 Aug; 34(8):935-41. PubMed ID: 21654755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study.
    Bakris GL; Weir MR; Shanifar S; Zhang Z; Douglas J; van Dijk DJ; Brenner BM;
    Arch Intern Med; 2003 Jul; 163(13):1555-65. PubMed ID: 12860578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinic and ambulatory pulse pressure segregate a cluster of cardiovascular risk factors.
    Ferrara LA; Guida L; Innelli P; Limauro S; Celentano A
    J Hum Hypertens; 2002 Oct; 16(10):719-24. PubMed ID: 12420196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulse pressure and chronic kidney disease in patients with type 2 diabetes.
    Tanaka M; Babazono T; Takeda M; Iwamoto Y
    Hypertens Res; 2006 May; 29(5):345-52. PubMed ID: 16832155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of albuminuria by different blood pressure measurement methods in type 1 diabetes: a pilot study.
    Stergiou GS; Alamara C; Drakatos A; Stefanidis CJ; Vazeou A
    Hypertens Res; 2009 Aug; 32(8):680-4. PubMed ID: 19498440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Home blood pressure is as reliable as ambulatory blood pressure in predicting target-organ damage in hypertension.
    Stergiou GS; Argyraki KK; Moyssakis I; Mastorantonakis SE; Achimastos AD; Karamanos VG; Roussias LG
    Am J Hypertens; 2007 Jun; 20(6):616-21. PubMed ID: 17531917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating cholesterol as a modulator of risk for renal injury in patients with type 2 diabetes.
    Earle KA; Harry D; Zitouni K
    Diabetes Res Clin Pract; 2008 Jan; 79(1):68-73. PubMed ID: 17766000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Value of ambulatory blood pressure monitoring in blood pressure profile determination in type 2 diabetes].
    Bezdah L; Ouerdiane D; Kamoun M; Abid H; Lamine F; Kasri R; Houissa SH; Belhani A
    Tunis Med; 2002 Dec; 80(12):769-74. PubMed ID: 12664504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Masked hypertension, urinary albumin excretion rate, and echocardiographic parameters in putatively normotensive type 2 diabetic patients.
    Leitão CB; Canani LH; Kramer CK; Boza JC; Pinotti AF; Gross JL
    Diabetes Care; 2007 May; 30(5):1255-60. PubMed ID: 17303786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for development of microalbuminuria in diabetic and nondiabetic normoalbuminuric hypertensives with high or very high cardiovascular risk - a twelve-month follow-up study.
    Cotter J; Oliveira P; Cunha P; Polónia J
    Nephron Clin Pract; 2009; 113(1):c8-15. PubMed ID: 19590230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of losartan in reducing microalbuminuria in normotensive patients with type-2 diabetes mellitus.
    Agha A; Bashir K; Anwar E
    Nepal Med Coll J; 2007 Jun; 9(2):79-83. PubMed ID: 17899953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update on the ROADMAP clinical trial report: olmesartan for the prevention or delay of microalbuminuria development in type 2 diabetes.
    Chatzikyrkou C; Menne J
    Expert Rev Cardiovasc Ther; 2012 Sep; 10(9):1087-92. PubMed ID: 23098143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ongoing treatment with renin-angiotensin-aldosterone-blocking agents does not predict normoalbuminuric renal impairment in a general type 2 diabetes population.
    Afghahi H; Miftaraj M; Svensson AM; Hadimeri H; Gudbjörnsdottir S; Eliasson B; Svensson MK;
    J Diabetes Complications; 2013; 27(3):229-34. PubMed ID: 23246248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulse pressure and systolic night-day ratio interact in prediction of macrovascular disease in patients with type 2 diabetes mellitus.
    Laugesen E; Rossen NB; Poulsen PL; Hansen KW; Ebbehøj E; Knudsen ST
    J Hum Hypertens; 2012 Mar; 26(3):164-70. PubMed ID: 21390057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes.
    Haller H; Ito S; Izzo JL; Januszewicz A; Katayama S; Menne J; Mimran A; Rabelink TJ; Ritz E; Ruilope LM; Rump LC; Viberti G;
    N Engl J Med; 2011 Mar; 364(10):907-17. PubMed ID: 21388309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulse pressure does not predict the response of diabetic nephropathy to glucose-lowering therapy.
    Nakhjavani M; Nargesi AA; Heidari B; Ghazizadeh Z; Larry M; Esteghamati A
    Diab Vasc Dis Res; 2015 Mar; 12(2):150-1. PubMed ID: 25525076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical value of ambulatory blood pressure: evidence and limits.
    Mancia G; Verdecchia P
    Circ Res; 2015 Mar; 116(6):1034-45. PubMed ID: 25767288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kidney-protective effects of azelnidipine versus a diuretic in combination with olmesartan in hypertensive patients with diabetes and albuminuria: a randomized study.
    Kojima M; Okubo S; Mizubayashi R; Isaka N; Machida H; Okamoto S; Hirota H; Takeuchi M; Kato T; Nakatani K; Mizuno O; Miyagawa K; Makino K; Okura T; Dohi Y; Ito M; Kimura G
    Nephrol Dial Transplant; 2013 Jul; 28(7):1802-10. PubMed ID: 23535223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.